xylocaine with adrenaline 2 (1:200,000 %v/v solution for injection
astrazeneca uk limited - lidocaine hydrochloride, epinephrine bitartrate - solution for injection - 2 (1:200,000 %v/v - amides
xylocaine 10mg/metered dose spray
astrazeneca ab - lidocaine 10 mg - cutaneous spray
xylocaine 10 mg/delivered dose mucosal spray
aspen pharma trading limited - lidocaine - oromucosal spray, solution - 10 milligram(s)/dose - lidocaine
xylocaine 2% with adrenaline (epinephrine) (1:200,000) solution for injection
aspen pharma trading limited - adrenaline tartrate; lidocaine hydrochloride - solution for injection - 2 (1:200,000 percent volume/volume - amides; lidocaine, combinations
xylocaine 10mg/dose spray
aspen pharma trading ltd - lidocaine - spray - 10mg/1actuation
xylocaine 10 mg/delivered dose mucosal spray
aspen pharma trading limited 3016 lake drive city west businees campus dublin 24, ireland - lidocaine - cutaneous spray - lidocaine 10 mg - anesthetics
2% xylocaine dental with adrenaline 1:80,000 2.2ml injection cartridge
dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.
xylocaine jelly
pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous; lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous - topical gel - 2% w/v - active: lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid methyl hydroxybenzoate methylcellulose propyl hydroxybenzoate purified water sodium hydroxide active: lidocaine hydrochloride monohydrate 21.3 mg/g equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid hypromellose methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium hydroxide - xylocaine 2% jelly is indicated as a surface anaesthetic and lubricant for: · the male and female urethra during cystoscopy, catheterisation, exploration by sound and other endourethral procedures. · nasal and pharyngeal cavities in endoscopic procedures such as gastroscopy and bronchoscopy. · during proctoscopy and rectoscopy. · tracheal intubation. · to relieve pain after circumcision in children.
xylocaine pump spray 10 %
padagis israel agencies ltd, israel - lidocaine - solution - lidocaine 10 mg / 0.1 ml - lidocaine - lidocaine - surface anaesthesia in dental practice otorhinolaryngology, obstetric and anaesthesiology.
xylocaine lidocaine hydrochloride injection solution
cardinal health - lidocaine hydrochloride anhydrous (unii: ec2cnf7xfp) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 20 mg in 1 ml